Nova One Advisor
Global post-operative pain management Market Size, Share, Forecast Report, 202...

Global post-operative pain management Market Size, Share, Forecast Report, 2020-2027

Status: Published Category: Healthcare Insight Code: 2841 Format: PDF / PPT / Excel

Content

Post-operative pain management is a branch of the that deals with the minimizing the pain occur due to tissue injury together with muscle spasm to the patients after surgery. It is the branch of pain management. Global post- operative pain management market is growing steadily due to increasing demand for the pain control drugs and devices. Increasing number of surgeries across the globe and increasing prevalence of different diseases across the globe is the major factor for the growth of the market. Increasing age rises the possibility of the different complication, this increasing aging population is also has a synergistic impact of the growth of the market. According to the Centre for Disease Control and Prevention during last decade due to overdose of the analgesic drugs number of deaths has increased. Analgesic drugs are habit forming drugs and thus side effects of the treatment and habit forming nature of the drugs can hamper the growth of the market.

Global Post-operative pain management market was expected to grow at a CAGR of 5.4% during forecasted period 2017-2023.
Key players for global post-operative pain management market

Teva Pharmaceutical Industries Ltd. (Israel), Eli Lilly (U.S), Pfizer (U.S), Johnson & Johnson (U.S), Purdue Pharma (U.S), Endo Pharmaceuticals Plc. (U.S), Forest Laboratories Inc. (U.S), GlaxoSmithKline Plc. (UK), F. Hoffmann-La Roche Ltd. (Switzerland), Baxter International Inc. (US), Valeant Pharmaceuticals International Inc. (Canada)

Segmentation

Global post-operative pain management market is segmented on the basis of pain type into acute pain, moderate pain and severe pain. On the basis of product they are segmented into non-steroidal anti-inflammatory drugs (NSAIDs), antiepileptic drugs, COX-2 inhibitors, opioids and other analgesics. On the basis of application they are segmented into cancer pain, arthritic pain, neuropathic pain, musculoskeletal pain, migraine and other and on the basis of target area they are back, legs, hand and arms and other.

  • Insight Code: 2841
  • No. of Pages: 250
  • Format: PDF/PPT/Excel
  • Published: July 2020
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034